Expression and prognostic value of epidermal growth factor receptor, transforming growth factor-α, and c-erb B-2 in nephroblastoma

Cancer

Volumn 92, Issue 12, 2001, Pages 3120-3129

  Ghanem, Mazen A ^a   Van Der Kwast, Theodorus H ^a   Den Hollander, Jan C ^b   Sudaryo, Mondastri K ^c   Mathoera, Rejiv B ^a   Van Den Heuvel, Marry M ^a   Noordzij, Marinus A ^b   Nijman, Rien J M ^c   Van Steenbrugge, Gert J ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

c erb B 2; Epidermal growth factor receptor (EGF R); Prognosis; Transforming growth factor (TGF ); Wilms

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PARAFFIN; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; AUTOCRINE EFFECT; BLASTEMA; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD CANCER; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY EPITHELIUM; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; ONCOGENE NEU; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STROMA CELL;

CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RISK FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MARKERS, BIOLOGICAL; WILMS TUMOR;

EID: 0035892763     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20011215)92:12<3120::AID-CNCR10173>3.0.CO;2-2     Document Type: Article

References (51)

1. Renal neoplasms of childhood
2. How curable is relapsed Wilms tumour?
3. Enhanced expression of insulin-like growth factor II is not a necessary in Wilms tumor progression
4. Expression of insulin-like growth factor-II transcripts in Wilms tumour
5. Recombinant human epidermal growth factor precursor is a glycosilated membrane protein with biological activity
6. Transforming growth factor-alpha
7. Epidermal growth factor - Minireview
8. Epidermal-growth-factor receptors in human bladder cancer: Comparison of invasive and superficial tumors
9. The prognostic value of epidermal growth factors receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study
10. Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of human lung
11. Expression of growth factor receptor in human gastric and colonic carcinomas
12. Autocrine growth factors and cancer
13. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma
14. Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells
15. Studies of HER-2/neu protooncogene in human breast and ovarian cancer
16. p185 neu expression in human lung adenocarcinomas predicts shortened survival
17. The new SIOP (Stockholm) working classification of renal tumours of childhood
18. Autocrine interaction between TGF-alpha and the EGF-receptor: Quantitative requirements for induction of the malignant phenotype
19. Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival
20. Prognostic significance of transforming growth factor-alpha in human esophageal carcinoma. Implication for the autocrine proliferation
21. Interrelationship between transforming growth factor-alpha and epidermal growth factor receptor in advanced gastric cancer
22. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness
23. Epidermal growth factor family and renal cell carcinoma: Expression and prognostic impact
24. Prognostic value of EGFR and TGF-alpha in early laryngeal cancer treated with radiotherapy
25. Transforming growth factor-α: A more potent angiogenic mediator than epidermal growth factor
26. The effect of transforming growth factor-α on airway angiogenesis
27. Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in gastric carcinoma
28. Expression of transforming growth factor-α and epidermal growth factor receptor messenger RNA in neoplastic and nonneoplastic human kidney tissue
29. Prognostic utility of epidermal growth factor receptor overexpression in endometrial adenocarcinoma
30. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis
31. The epidermal growth factor receptor as a prognostic marker: Results of 370 patients and review of 3009 patients
32. The expression of epidermal growth factor receptor and transforming growth factor-alpha in renal cell carcinoma
33. The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma
34. Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer, but does not predict tumor progression
35. Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: Evidence for downregulation in cervical cancer
36. Levels of TGF-α and EGFR protein in head and neck squamous cell carcinoma and patient survival
37. Aberrant expression of epidermal growth factor receptor and HER-2 (erbB-2) messenger RNAs in human renal cancers
38. Expression of HER-2/neu renal-cell carcinoma. Correlation with histologic subtypes and differentiation
39. Expression of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and in the pacenta
40. Distribution of neu (c-erbB2) protein in human skin
41. Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas
42. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene
43. An immunohistologic evaluation of c-erbB-2 gene product in patients with urinary bladder carcinoma
44. Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer
45. Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression
46. Hormone resistant prostatic adenocarcinoma, an evaluation of prognostic factors in pre-and post-treatment specimens
47. Expression of epidermal growth factor (EGF) and the EGF receptor in human tissues
48. Co-expression of epidermal growth factor receptor and TGF-alpha and survival in upper aerodigestive tract cancer
49. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients
50. Transforming growth factor-alpha-pseudomonas exotoxin fusion protein (TGF-alpha-PE38) treatment of subcutaneous and intracranial human glioma and medulloblastoma xenografts in athymic mice
51. The epidermal growth factor receptor as a target for therapy in breast carcinoma